Qube Research & Technologies LTD Medicinova Inc Transaction History

Qube Research & Technologies LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.57 $1,342 - $1,646	-1,049 Reduced 97.04%	32 $0
Q1 2024 May 14, 2024	SELL	$1.28 - $1.65 $2,090 - $2,694	-1,633 Reduced 60.17%	1,081 $1,000
Q4 2023 Feb 13, 2024	BUY	$1.38 - $2.06 $3,701 - $5,524	2,682 Added 8381.25%	2,714 $4,000
Q3 2023 Nov 13, 2023	BUY	$2.01 - $2.6 $64 - $83	32 New	32 $0
Q4 2022 Feb 14, 2023	SELL	$1.97 - $2.66 $48,513 - $65,505	-24,626 Reduced 70.23%	10,440 $21,000
Q3 2022 Nov 14, 2022	BUY	$2.1 - $2.6 $20,496 - $25,376	9,760 Added 38.57%	35,066 $76,000
Q2 2022 Aug 15, 2022	BUY	$2.31 - $3.14 $58,456 - $79,460	25,306 New	25,306 $64,000
Q1 2022 May 09, 2022	SELL	$2.19 - $2.81 $30,215 - $38,769	-13,797 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$2.61 - $4.42 $36,010 - $60,982	13,797 New	13,797 $37,000

4.83M

9.4K

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $106M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.